On the structure of cardiovascular risk factors in male military personnel with myocardial infarction and chronic inflammatory lung diseases

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The structural features of cardiovascular risk factors in military personnel with chronic inflammatory pulmonary diseases during myocardial infarction were assessed to improve prevention. The study included male military personnel aged 19–60 years with type I myocardial infarction. The patients were divided into two age-matched groups: I – study group, with chronic inflammatory lung diseases – 10 patients; II – control, without them – 72 patients. A comparative analysis of the frequency of observation of main and additional cardiovascular risk factors in the selected groups was performed. Patients in the study group do not differ from the control group in the frequency of most of the main and additional risk factors for cardiovascular pathology, except for smoking (100% in the study group and 65.3% in the comparison group; p=0.01) and chronic infections of internal organs (100 and 26.4%, respectively; р<0.0001). In the study group, more pronounced disturbances of carbohydrate metabolism were revealed in the first hours of myocardial infarction and lipid metabolism at the end of the subacute period of the disease, which indicates a less favorable prognosis of the disease and the need for appropriate preventive measures .

Full Text

Restricted Access

About the authors

A. V. Gordienko

The S.M.Kirov Military Medical Academy of Ministry of Defense of the Russian Federation

Email: vmeda-nio@mail.ru

заслуженный врач РФ, профессор, полковник медицинской службы запаса

Russian Federation, St. Petersburg

A. V. Sotnikov

The S.M.Kirov Military Medical Academy of Ministry of Defense of the Russian Federation

Author for correspondence.
Email: vmeda-nio@mail.ru

доктор медицинских наук, доцент, полковник медицинской службы

Russian Federation, St. Petersburg

A. N. Menshikova

The S.M.Kirov Military Medical Academy of Ministry of Defense of the Russian Federation

Email: vmeda-nio@mail.ru

капитан медицинской службы

Russian Federation, St. Petersburg

D. V. Nosovich

The S.M.Kirov Military Medical Academy of Ministry of Defense of the Russian Federation

Email: vmeda-nio@mail.ru

кандидат медицинских наук, капитан медицинской службы

Russian Federation, St. Petersburg

References

  1. Будневский А.В., Малыш Е.Ю. Хроническая обструктивная болезнь легких как фактор риска развития сердечно-сосудистых заболеваний // Кардиоваскулярная терапия и профилактика. – 2016. – Т. 15, № 3. – С. 69–73. DOI.org/10.15829/1728-8800-2016-3-69-73
  2. Крюков Е.В., Тришкин Д.В., Салухов В.В., Ивченко Е.В. Опыт военной медицины в борьбе с новой коронавирусной инфекцией // Вестн. Рос. акад. наук. – 2022. – Т. 92, № 7. – С. 699–706. doi: 10.31857/S086958732207009X
  3. Масимова А.Э., Мамедов М.Н. Особенности факторов риска сердечно-сосудистых заболеваний и ишемической болезни сердца среди военнослужащих // Кардиоваскулярная терапия и профилактика. – 2021. – T. 20, № 1. – С. 71–75. doi: 10.15829/1728-8800-2021-2702
  4. Сотников А.В., Гордиенко А.В., Чинь Ван Нхан и др. Особенности кардиоваскулярных факторов риска у мужчин моложе 60 лет с острым повреждением почек при инфаркте миокарда // Медико-фармацевтический журнал Пульс. – 2020. – Т. 22, № 4. – С. 120–127. doi: 10.26787/nydha-2686-6838-2020-22-4-120-127
  5. Сычев А.Д., Бордовский С.П., Данилина К.С., Ильина Е.С. Потенциально нерекомендованные лекарственные средства для пациентов пожилого и старческого возраста: STOPP/START критерии // Клин. фармакол. терапия. – 2016. – Т. 25., № 2. – С. 76–81.
  6. Adamson A., Portas L., Accordini S. et al. Communication of personalised disease risk by general practitioners to motivate smoking cessation in England: a cost-effectiveness and research prioritisation study // Addiction. – 2022. – Vol. 117, N 5. – P. 1438–1449. doi: 10.1111/add.15773
  7. Diaz A.A., Young T.P., Kurugol S. et al. Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD // Chronic. Obstr. Pulm. Dis. – 2015. – Vol. 2, N 1. – P. 8–16. DOI: 10.15326jcopdf.2.1. 2014.0127
  8. Goniewicz M.L., Miller C.R., Sutanto E., Li D. How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review // Harm Reduct. J. – 2020. – Vol. 17, N 1. – P. 91. doi: 10.1186/s12954-020-00440-w
  9. Hanefeld C., Haschemi A., Lampert T. et al. Social Gradients in Myocardial Infarction and Stroke Diagnoses in Emergency Medicine // Dtsch. Arztebl. Int. – 2018. – Vol. 115, N 4. – P. 41–48. doi: 10.3238/arztebl.2018.0041
  10. Harris B.F., Winn C., Ableman T.B. Hemorrhagic Stroke in a Young Healthy Male Following Use of Pre-Workout Supplement Animal Rage XL // Mil. Med. – 2017. – Vol. 182, N 9. – P. e2030–e2033. doi: 10.7205/MILMED-D-17-00013
  11. Hughes W.S. An hypothesis: the dramatic decline in heart attacks in the United States is temporally related to the decline in duodenal ulcer disease and Helicobacter pylori infection // Helicobacter. – 2014. – Vol. 19, N 3. – P. 239–241. doi: 10.1111/hel.12123
  12. Kunisaki K.M., Dransfield M.T., Anderson J.A. et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial // Am. J. Respir. Crit. Care Med. – 2018. – Vol. 198, N 1. – P. 51–57. doi: 10.1164/rccm.201711-2239OC
  13. Lovatt S., Wong C.W., Holroyd E. et al. Smoking cessation after acute coronary syndrome: A systematic review and meta-analysis // Int. J. Clin. Pract. – 2021. – Vol. 75, N 12. – P. e14894. doi: 10.1111/ijcp.14894
  14. Makam R.C., Erskine N., McManus D.D. et al. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction // Am. J. Cardiol. – 2016. – Vol. 118, N 12. – P. 1792–1797. doi: 10.1016/j.amjcard.2016.08.065
  15. Sundaram V., Quint J.K. Chronic obstructive pulmonary disease and myocardial infarction: when will we get our act together? // Eur. Heart J. Qual. Care Clin. Outcomes. – 2020. – Vol. 6, N 1. – P. 1–2. doi: 10.1093/ehjqcco/qcz016
  16. Taylor C.L., Eckart R.E. Chest pain, ST elevation, and positive cardiac enzymes in an austere environment: differentiating smallpox vaccination-mediated myocarditis and acute coronary syndrome in Operation Iraqi Freedom // J. Emerg. Med. – 2012. – Vol. 42, Iss. 3. – P. 267–270. doi: 10.1016/j.jemermed. 2008.08.027
  17. Terrosu P. Relapse of chronic obstructive pulmonary disease and myocardial infarction: what is the connection? // Eur. Heart J. Suppl. – 2020. – Vol. 22, Suppl. L. – Р. L151–L154. doi: 10.1093/eurheartj/suaa156
  18. Yayan J. No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease // Int. J. Med. Sci. – 2015. – Vol. 12, N 3. – P. 280–287. doi: 10.7150/ijms.11054

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig.1.

Download (397KB)
Indexing metadata

Copyright (c) 2024 Gordienko A.V., Sotnikov A.V., Menshikova A.N., Nosovich D.V.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies